Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration

Mitochondrion

Volumn 19, Issue Part A, 2014, Pages 88-96

  Sorrentino, Giovanni ^a,b   Comel, Anna ^a,b   Mantovani, Fiamma ^a,b   Del Sal, Giannino ^a,b  

^a Laboratorio Nazionale CIB   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Apoptosis; Cancer; Mitochondria; P53; Pin1

Indexed keywords

PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN P53; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BREAST CANCER; COLON CANCER; ESOPHAGUS CANCER; GENE; GENE ACTIVITY; GENE CONTROL; GENE FUNCTION; GENE STRUCTURE; GLIOBLASTOMA; HUMAN; HUNTINGTON CHOREA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MITOCHONDRIAL DYNAMICS; MOUTH SQUAMOUS CELL CARCINOMA; NERVE DEGENERATION; NONHUMAN; OVARY TUMOR; PATHOGENESIS; PIN1 GENE; PROSTATE CANCER; REGULATORY MECHANISM; UTERINE CERVIX CANCER; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION; NEOPLASM; PHYSIOLOGY;

APOPTOSIS; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; NEOPLASMS; NEURODEGENERATIVE DISEASES; PEPTIDYLPROLYL ISOMERASE;

EID: 84911062657     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.08.003     Document Type: Article

References (130)

1. Altieri D.C. Survivin in apoptosis control and cell cycle regulation in cancer. Prog. Cell Cycle Res. 2003, 5:447-452.
2. Atchison F.W., Means A.R. Spermatogonial depletion in adult Pin1-deficient mice. Biol. Reprod. 2003, 69:1989-1997.
3. Atkinson G.P., Nozell S.E., Harrison D.K., Stonecypher M.S., Chen D., Benveniste E.N. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 2009, 28:3735-3745.
4. Ayala G., Wang D., Wulf G., Frolov A., Li R., Sowadski J., Wheeler T.M., Lu K.P., Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003, 63:6244-6251.
5. Bao L., Kimzey A., Sauter G., Sowadski J.M., Lu K.P., Wang D.G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164:1727-1737.
6. Becker E.B., Bonni A. Pin1 mediates neural-specific activation of the mitochondrial apoptotic machinery. Neuron 2006, 49:655-662.
7. Bergamaschi D., Gasco M., Hiller L., Sullivan A., Syed N., Trigiante G., Yulug I., Merlano M., Numico G., Comino A., Attard M., Reelfs O., Gusterson B., Bell A.K., Heath V., Tavassoli M., Farrell P.J., Smith P., Lu X., Crook T. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 2003, 3:387-402.
8. Bernardi R., Pandolfi P.P. A Dialog on the First 20 Years of PML Research and the Next 20 Ahead. Front Oncol. 2014, 4:23.
9. Bernardi R., Papa A., Pandolfi P.P. Regulation of apoptosis by PML and the PML-NBs. Oncogene 2008, 27:6299-6312.
10. Bialik S., Kimchi A. The DAP-kinase interactome. Apoptosis 2014, 19:316-328.
11. Bitomsky N., Conrad E., Moritz C., Polonio-Vallon T., Sombroek D., Schultheiss K., Glas C., Greiner V., Herbel C., Mantovani F., del Sal G., Peri F., Hofmann T.G. Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E4203-E4212.
12. Breen A.P., Murphy J.A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 1995, 18:1033-1077.
13. Brenkman A.B., de Keizer P.L., van den Broek N.J., van der Groep P., van Diest P.J., van der Horst A., Smits A.M., Burgering B.M. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res. 2008, 68:7597-7605.
14. Campisi J. Aging, tumor suppression and cancer: high wire-act!. Mech. Ageing Dev. 2005, 126:51-58.
15. Campisi J., d'Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
16. Catala-Lopez F., Suarez-Pinilla M., Suarez-Pinilla P., Valderas J.M., Gomez-Beneyto M., Martinez S., Balanza-Martinez V., Climent J., Valencia A., McGrath J., Crespo-Facorro B., Sanchez-Moreno J., Vieta E., Tabarés-Seisdedos R. Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies. Psychother. Psychosom. 2014, 83:89-105.
17. Chen Y.L., Yan M.Y., Chien S.Y., Kuo S.J., Chen D.R., Cheng C.Y., Su C.C. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-alpha, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro. Mol. Med. Rep. 2013, 7:1487-1493.
18. Chipuk J.E., Bouchier-Hayes L., Kuwana T., Newmeyer D.D., Green D.R. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005, 309:1732-1735.
19. Comel A., Sorrentino G., Capaci V., Del Sal G. The cytoplasmic side of p53's oncosuppressive activities. FEBS Lett. 2014, 588:2600-2609.
20. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17:1195-1214.
21. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G., Piaggio G., Fanciulli M., Appella E., Soddu S. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 2002, 4:11-19.
22. Dauth I., Kruger J., Hofmann T.G. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res. 2007, 67:2274-2279.
23. De Nicola F., Bruno T., Iezzi S., Di Padova M., Floridi A., Passananti C., Del Sal G., Fanciulli M. The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. J. Biol. Chem. 2007, 282:19685-19691.
24. Di Stefano V., Rinaldo C., Sacchi A., Soddu S., D'Orazi G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp. Cell Res. 2004, 293:311-320.
25. Ding Q., Huo L., Yang J.Y., Xia W., Wei Y., Liao Y., Chang C.J., Yang Y., Lai C.C., Lee D.F., Yen C.J., Chen Y.J., Hsu J.M., Kuo H.P., Lin C.Y., Tsai F.J., Li L.Y., Tsai C.H., Hung M.C. Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res. 2008, 68:6109-6117.
26. Dizdaroglu M., Jaruga P., Birincioglu M., Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 2002, 32:1102-1115.
27. Dourlen P., Ando K., Hamdane M., Begard S., Buee L., Galas M.C. The peptidyl prolyl cis/trans isomerase Pin1 downregulates the Inhibitor of Apoptosis Protein Survivin. Biochim. Biophys. Acta 2007, 1773:1428-1437.
28. Eckerdt F., Yuan J., Saxena K., Martin B., Kappel S., Lindenau C., Kramer A., Naumann S., Daum S., Fischer G., Dikic I., Kaufmann M., Strebhardt K. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem. 2005, 280:36575-36583.
29. Flores E.R., Tsai K.Y., Crowley D., Sengupta S., Yang A., McKeon F., Jacks T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002, 416:560-564.
30. Galanis A., Pappa A., Giannakakis A., Lanitis E., Dangaj D., Sandaltzopoulos R. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008, 266:12-20.
31. Giam M., Huang D.C., Bouillet P. BH3-only proteins and their roles in programmed cell death. Oncogene 2008, 27(Suppl. 1):S128-S136.
32. Girardini J.E., Napoli M., Piazza S., Rustighi A., Marotta C., Radaelli E., Capaci V., Jordan L., Quinlan P., Thompson A., Mano M., Rosato A., Crook T., Scanziani E., Means A.R., Lozano G., Schneider C., Del Sal A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 2011, 20:79-91.
33. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
34. Grison A., Mantovani F., Comel A., Agostoni E., Gustincich S., Persichetti F., Del Sal G. Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17979-17984.
35. Gurrieri C., Capodieci P., Bernardi R., Scaglioni P.P., Nafa K., Rush L.J., Verbel D.A., Cordon-Cardo C., Pandolfi P.P. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 2004, 96:269-279.
36. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
37. Hitosugi T., Zhou L., Elf S., Fan J., Kang H.B., Seo J.H., Shan C., Dai Q., Zhang L., Xie J., Gu T.L., Jin P., Aleckovic M., LeRoy G., Kang Y., Sudderth J.A., DeBerardinis R.J., Luan C.H., Chen G.Z., Muller S., Shin D.M., Owonikoko T.K., Lonial S., Arellano M.L., Khoury H.J., Khuri F.R., Lee B.H., Ye K., Boggon T.J., Kang S., He C., Chen J. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 2012, 22:585-600.
38. Hofmann T.G., Moller A., Sirma H., Zentgraf H., Taya Y., Droge W., Will H., Schmitz M.L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 2002, 4:1-10.
39. Hofmann T.G., Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 2003, 10:1290-1299.
40. Ibanez K., Boullosa C., Tabares-Seisdedos R., Baudot A., Valencia A. Molecular Evidence for the Inverse Comorbidity between Central Nervous System Disorders and Cancers Detected by Transcriptomic Meta-analyses. PLoS Genet. 2014, 10:e1004173.
41. Illuzzi J., Yerkes S., Parekh-Olmedo H., Kmiec E.B. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates. J. Neurosci. Res. 2009, 87:733-747.
42. Irwin M., Marin M.C., Phillips A.C., Seelan R.S., Smith D.I., Liu W., Flores E.R., Tsai K.Y., Jacks T., Vousden K.H., Kaelin W.G. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000, 407:645-648.
43. Ito T., Shiraki K., Sugimoto K., Yamanaka T., Fujikawa K., Ito M., Takase K., Moriyama M., Kawano H., Hayashida M., Nakano T., Suzuki A. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 2000, 31:1080-1085.
44. Jentsch S., Siepe D. Pin1, a novel switch in the ubiquitin pathway. Cell Cycle 2009, 8:3800-3801.
45. Jin H., Jiang J., Sun L., Zheng F., Wu C., Peng L., Zhao Y., Wu X. The prolyl isomerase Pin1 is overexpressed in human esophageal cancer. Oncol. Lett. 2011, 2:1191-1196.
46. Karbowski M., Lee Y.J., Gaume B., Jeong S.Y., Frank S., Nechushtan A., Santel A., Fuller M., Smith C.L., Youle R.J. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 2002, 159:931-938.
47. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
48. Kvansakul M., Yang H., Fairlie W.D., Czabotar P.E., Fischer S.F., Perugini M.A., Huang D.C., Colman P.M. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 2008, 15:1564-1571.
49. Lartigue L., Kushnareva Y., Seong Y., Lin H., Faustin B., Newmeyer D.D. Caspase-independent mitochondrial cell death results from loss of respiration, not cytotoxic protein release. Mol. Biol. Cell 2009, 20:4871-4884.
50. Lee G.H., Joo Y.E., Koh Y.S., Chung I.J., Park Y.K., Lee J.H., Kim H.S., Choi S.K., Rew J.S., Park C.S., Kim S.J. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur. J. Gastroenterol. Hepatol. 2006, 18:957-963.
51. Lee S.T., Li Z., Wu Z., Aau M., Guan P., Karuturi R.K., Liou Y.C., Yu Q. Context-specific regulation of NF-kappaB target gene expression by EZH2 in breast cancers. Mol. Cell 2011, 43:798-810.
52. Lee T.H., Pastorino L., Lu K.P. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert. Rev. Mol. Med. 2011, 13:e21.
53. Letai A., Sorcinelli M.D., Beard C., Korsmeyer S.J. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell 2004, 6:241-249.
54. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584.
55. Li H., Wang S., Zhu T., Zhou J., Xu Q., Lu Y., Ma D. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression. Oncol. Rep. 2006, 16:491-496.
56. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
57. Liou Y.C., Ryo A., Huang H.K., Lu P.J., Bronson R., Fujimori F., Uchida T., Hunter T., Lu K.P. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1335-1340.
58. Liou Y.C., Zhou X.Z., Lu K.P. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci. 2011, 36:501-514.
59. Locasale J.W., Grassian A.R., Melman T., Lyssiotis C.A., Mattaini K.R., Bass A.J., Heffron G., Metallo C.M., Muranen T., Sharfi H., Sasaki A.T., Anastasiou D., Mullarky E., Vokes N.I., Sasaki M., Beroukhim R., Stephanopoulos G., Ligon A.H., Meyerson M., Richardson A.L., Chin L., Wagner G., Asara J.M., Brugge J.S., Cantley L.C., Vander Heiden M.G. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 2011, 43:869-874.
60. Lohrum M.A., Woods D.B., Ludwig R.L., Balint E., Vousden K.H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 2001, 21:8521-8532.
61. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
62. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
63. Lu P.J., Zhou X.Z., Liou Y.C., Noel J.P., Lu K.P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 2002, 277:2381-2384.
64. Lv L., Zhou Z., Huang X., Zhao Y., Zhang L., Shi Y., Sun M., Zhang J. Inhibition of peptidyl-prolyl cis/trans isomerase Pin1 induces cell cycle arrest and apoptosis in vascular smooth muscle cells. Apoptosis 2010, 15:41-54.
65. MacLachlan T.K., Somasundaram K., Sgagias M., Shifman Y., Muschel R.J., Cowan K.H., El-Deiry W.S. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 2000, 275:2777-2785.
66. Magli A., Angelelli C., Ganassi M., Baruffaldi F., Matafora V., Battini R., Bachi A., Messina G., Rustighi A., Del Sal G., Ferrari S., Molinari S. Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. J. Biol. Chem. 2010, 285:34518-34527.
67. Mancini F., Di Conza G., Pellegrino M., Rinaldo C., Prodosmo A., Giglio S., D'Agnano I., Florenzano F., Felicioni L., Buttitta F., Marchetti A., Sacchi A., Pontecorvi A., Soddu S., Moretti F. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J. 2009, 28:1926-1939.
68. Mancini F., Moretti F. Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle 2009, 8:3854-3859.
69. Mantovani F., Piazza S., Gostissa M., Strano S., Zacchi P., Mantovani R., Blandino G., Del Sal G. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 2004, 14:625-636.
70. Mantovani F., Tocco F., Girardini J., Smith P., Gasco M., Lu X., Crook T., Del Sal G. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat. Struct. Mol. Biol. 2007, 14:912-920.
71. Marchenko N.D., Wolff S., Erster S., Becker K., Moll U.M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 2007, 26:923-934.
72. Miyashita H., Mori S., Motegi K., Fukumoto M., Uchida T. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol. Rep. 2003, 10:455-461.
73. Moll U.M., Wolff S., Speidel D., Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 2005, 17:631-636.
74. Moller P., Wallin H. Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product. Mutat. Res. 1998, 410:271-290.
75. Nakamura K., Kosugi I., Lee D.Y., Hafner A., Sinclair D.A., Ryo A., Lu K.P. Prolyl isomerase Pin1 regulates neuronal differentiation via beta-catenin. Mol. Cell. Biol. 2012, 32:2966-2978.
76. O'Connor D.S., Grossman D., Plescia J., Li F., Zhang H., Villa A., Tognin S., Marchisio P.C., Altieri D.C. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13103-13107.
77. Palaga T., Ratanabunyong S., Pattarakankul T., Sangphech N., Wongchana W., Hadae Y., Kueanjinda P. Notch signaling regulates expression of Mcl-1 and apoptosis in PPD-treated macrophages. Cell. Mol. Immunol. 2013, 10:444-452.
78. Paneni F., Costantino S., Castello L., Battista R., Capretti G., Chiandotto S., D'Amario D., Scavone G., Villano A., Rustighi A., Crea F., Pitocco D., Lanza G., Volpe M., Del Sal G., Lüscher T.F., Cosentino F. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. Eur. Heart J. 2014, 34:2444-2452.
79. Papazoglu C., Mills A.A. p53: at the crossroad between cancer and ageing. J. Pathol. 2007, 211:124-133.
80. Pastorino L., Ma S.L., Balastik M., Huang P., Pandya D., Nicholson L., Lu K.P. Alzheimer's disease-related loss of Pin1 function influences the intracellular localization and the processing of AbetaPP. J. Alzheimers Dis. 2012, 30:277-297.
81. Pastorino L., Sun A., Lu P.J., Zhou X.Z., Balastik M., Finn G., Wulf G., Lim J., Li S.H., Li X., Xia W., Nicholson L.K., Lu K.P. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440:528-534.
82. Pinton P., Giorgi C., Pandolfi P.P. The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. Cell Death Differ. 2011, 18:1450-1456.
83. Pinton P., Giorgi C., Siviero R., Zecchini E., Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 2008, 27:6407-6418.
84. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., Contursi C., Minucci S., Mantovani F., Wieckowski M.R., Del Sal G., Pelicci P.G., Rizzuto R. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007, 315:659-663.
85. Pinton P., Rizzuto R. p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria. Cell Cycle 2008, 7:304-308.
86. Plun-Favreau H., Lewis P.A., Hardy J., Martins L.M., Wood N.W. Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet. 2010, 6:e1001257.
87. Possemato R., Marks K.M., Shaul Y.D., Pacold M.E., Kim D., Birsoy K., Sethumadhavan S., Woo H.K., Jang H.G., Jha A.K., Chen W.W., Barrett F.G., Stransky N., Tsun Z.Y., Cowley G.S., Barretina J., Kalaany N.Y., Hsu P.P., Ottina K., Chan A.M., Yuan B., Garraway L.A., Root D.E., Mino-Kenudson M., Brachtel E.F., Driggers E.M., Sabatini D.M. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476:346-350.
88. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997, 275:967-969.
89. Ranganathan R., Lu K.P., Hunter T., Noel J.P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89:875-886.
90. Reineke E.L., Lam M., Liu Q., Liu Y., Stanya K.J., Chang K.S., Means A.R., Kao H.Y. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol. Cell. Biol. 2008, 28:997-1006.
91. Rippmann J.F., Hobbie S., Daiber C., Guilliard B., Bauer M., Birk J., Nar H., Garin-Chesa P., Rettig W.J., Schnapp A. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ. 2000, 11:409-416.
92. Ruan L., Torres C.M., Qian J., Chen F., Mintz J.D., Stepp D.W., Fulton D., Venema R.C. Pin1 prolyl isomerase regulates endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 2011, 31:392-398.
93. Rustighi A., Tiberi L., Soldano A., Napoli M., Nuciforo P., Rosato A., Kaplan F., Capobianco A., Pece S., Di Fiore P.P., Del Sal G. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 2009, 11:133-142.
94. Rustighi A., Zannini A., Tiberi L., Sommaggio R., Piazza S., Sorrentino G., Nuzzo S., Tuscano A., Eterno V., Benvenuti F., Santarpia L., Aifantis I., Rosato A., Bicciato S., Zambelli A., Del Sal G. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO. Mol. Med. 2014, 6:99-119.
95. Rustighi A., Zannini A., Tiberi L., Sommaggio R., Piazza S., Sorrentino G., Nuzzo S., Tuscano A., Eterno V., Benvenuti F., Santarpia L., Aifantis I., Rosato A., Bicciato S., Zambelli A., Del Sal G. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO. Mol. Med. 2014, 6.
96. Ryo A., Hirai A., Nishi M., Liou Y.C., Perrem K., Lin S.C., Hirano H., Lee S.W., Aoki I. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. J. Biol. Chem. 2007, 282:36671-36681.
97. Ryo A., Liou Y.C., Wulf G., Nakamura M., Lee S.W., Lu K.P. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 2002, 22:5281-5295.
98. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., Rottapel R., Yamaoka S., Lu K.P. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003, 12:1413-1426.
99. Ryo A., Uemura H., Ishiguro H., Saitoh T., Yamaguchi A., Perrem K., Kubota Y., Lu K.P., Aoki I. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 2005, 11:7523-7531.
100. Salomoni P., Guernah I., Pandolfi P.P. The PML-nuclear body associated protein Daxx regulates the cellular response to CD40. Cell Death Differ. 2006, 13:672-675.
101. Sanchez-Prieto R., Sanchez-Arevalo V.J., Servitja J.M., Gutkind J.S. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene 2002, 21:974-979.
102. Schinzel A., Kaufmann T., Borner C. Bcl-2 family members: integrators of survival and death signals in physiology and pathology [corrected]. Biochim. Biophys. Acta 2004, 1644:95-105.
103. Shen M., Stukenberg P.T., Kirschner M.W., Lu K.P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 1998, 12:706-720.
104. Shen Z.J., Esnault S., Schinzel A., Borner C., Malter J.S. The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation. Nat. Immunol. 2009, 10:257-265.
105. Siepe D., Jentsch S. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation. Nat. Cell Biol. 2009, 11:967-972.
106. Song J.J., Lee Y.J. Daxx deletion mutant (amino acids 501-625)-induced apoptosis occurs through the JNK/p38-Bax-dependent mitochondrial pathway. J. Cell. Biochem. 2004, 92:1257-1270.
107. Sorrentino G., Mioni M., Giorgi C., Ruggeri N., Pinton P., Moll U., Mantovani F., Del Sal G. The prolyl-isomerase Pin1 activates the mitochondrial death program of p53. Cell Death Differ. 2013, 20:198-208.
108. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., Markesbery W.R., Zhou X.Z., Lu K.P., Butterfield D.A. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol. Aging 2006, 27:918-925.
109. Takahashi Y., Lallemand-Breitenbach V., Zhu J., de The H. PML nuclear bodies and apoptosis. Oncogene 2004, 23:2819-2824.
110. Tsujimoto Y., Cossman J., Jaffe E., Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985, 228:1440-1443.
111. Uchida T., Takamiya M., Takahashi M., Miyashita H., Ikeda H., Terada T., Matsuo Y., Shirouzu M., Yokoyama S., Fujimori F., Hunter T. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 2003, 10:15-24.
112. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
113. Vaseva A.V., Marchenko N.D., Moll U.M. The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle 2009, 8:1711-1719.
114. Vaseva A.V., Moll U.M. The mitochondrial p53 pathway. Biochim. Biophys. Acta 2009, 1787:414-420.
115. Vaux D.L. Apoptogenic factors released from mitochondria. Biochim. Biophys. Acta 2011, 1813:546-550.
116. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-442.
117. Wallace D.C. Mitochondria and cancer: Warburg addressed. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:363-374.
118. Wallace D.C. Mitochondria and cancer. Nat. Rev. Cancer 2012, 12:685-698.
119. Wang D., Kreutzer D.A., Essigmann J.M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 1998, 400:99-115.
120. Wang S., Simon B.P., Bennett D.A., Schneider J.A., Malter J.S., Wang D.S. The significance of Pin1 in the development of Alzheimer's disease. J. Alzheimers Dis. 2007, 11:13-23.
121. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5:14.
122. Wasiak S., Zunino R., McBride H.M. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J. Cell Biol. 2007, 177:439-450.
123. Wulf G., Garg P., Liou Y.C., Iglehart D., Lu K.P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 2004, 23:3397-3407.
124. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
125. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 2007, 7:381-388.
126. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
127. Yun H.J., Kim J.Y., Kim G., Choi H.S. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression. Anticancer Res. 2014, 34:1409-1416.
128. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., Ronai Z., Blandino G., Schneider C., Del Sal G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419:853-857.
129. Zaffaroni N., Pennati M., Daidone M.G. Survivin as a target for new anticancer interventions. J. Cell. Mol. Med. 2005, 9:360-372.
130. Zheng H., You H., Zhou X.Z., Murray S.A., Uchida T., Wulf G., Gu L., Tang X., Lu K.P., Xiao Z.X. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419(6909):849-853.